Literature DB >> 10093050

Hypoxia-reoxygenation and polyunsaturated fatty acids modulate adrenergic functions in cultured cardiomyocytes.

P Delerive1, F Oudot, B Ponsard, S Talpin, J P Sergiel, C Cordelet, P Athias, A Grynberg.   

Abstract

The polyunsaturated fatty acids (PUFAs) of the omega 3 series are known to modulate adrenergic functions in ventricular myocytes. This study evaluated the influence of hypoxia duration and PUFA composition on the ability of cultured rat cardiomyocytes in producing alpha- and beta-adrenergic messengers (IPs and cAMP). After hypoxia (1.5, 2.5 or 3.5 h) followed by reoxygenation (1h). IP and cAMP production was induced by phenylephrine or isoproterenol stimulation, respectively. Hypoxia did not affect the basal level of messenger production in unstimulated cells, but decreased the cAMP production elicited by isoproterenol stimulation (up to 50%). The decrease in IP production after phenylephrine stimulation was observed only after long-term hypoxia duration close to irreversible cellular damages. The use of modified culture media supplemented with either arachidonic acid (AA) or docosahexaenoic acid (DHA) induced cardiomyocytes displaying either an arachidonic acid membrane profile (35% AA and 2% DHA in the phospholipids) or a docosahexaenoic acid membrane profile (15% AA and 20% DHA). These modifications did not alter the basal level of either messenger production in unstimulated cells nor the IP released after alpha-adrenergic stimulation. Conversely, the decrease in cAMP production was significantly more pronounced in docosahexaenoic acid-enriched cells than in arachidonic acid-enriched cells. This study suggests that hypoxia alters the beta-adrenergic messenger production, and that the alpha-system may balance the depression of the beta-system. The depression of the beta-adrenergic function induced by the incorporation of docosahexaenoic acid in membrane phospholipids may contribute to the beneficial effect of this fatty acid in the reperfused heart.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10093050     DOI: 10.1006/jmcc.1998.0871

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo.

Authors:  Monte S Willis; Amro Ilaiwy; Megan D Montgomery; Paul C Simpson; Brian C Jensen
Journal:  Metabolomics       Date:  2016-09-15       Impact factor: 4.290

2.  Cross-influence of membrane polyunsaturated fatty acids and hypoxia-reoxygenation on alpha- and beta-adrenergic function of rat cardiomyocytes.

Authors:  B Ponsard; I Durot; P Delerive; F Oudot; C Cordelet; A Grynberg; P Athias
Journal:  Lipids       Date:  1999-05       Impact factor: 1.880

3.  Docosahexaenoic Acid (DHA) Induced Morphological Differentiation of Astrocytes Is Associated with Transcriptional Upregulation and Endocytosis of β2-AR.

Authors:  Moitreyi Das; Sumantra Das
Journal:  Mol Neurobiol       Date:  2018-07-27       Impact factor: 5.590

4.  Changes in HSP70 and P53 expression are related to the pattern of electromechanical alterations in rat cardiomyocytes during simulated ischemia.

Authors:  A Laubriet; E Fantini; M Assem; C Cordelet; J R Teyssier; P Athias; L Rochette
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

Review 5.  Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death.

Authors:  P L McLennan; M Y Abeywardena
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

6.  Protective effects of EPA and deleterious effects of DHA on eNOS activity in Ea hy 926 cultured with lysophosphatidylcholine.

Authors:  Sylviane Tardivel; Aurélie Gousset-Dupont; Véronique Robert; Marie-Luce Pourci; Alain Grynberg; Bernard Lacour
Journal:  Lipids       Date:  2009-02-04       Impact factor: 1.880

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.